Drug Report History #35007
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v28-EN | Version v27-FR | |
|---|---|---|
| Language (Changed) | Updated to: English | Was: French |
| Date Updated (Changed) | Updated to: 2018-08-09 | Was: 2018-06-25 |
| Drug Identification Number | 02431130 | 02431130 |
| Brand name | VINORELBINE INJECTION, USP | VINORELBINE INJECTION, USP |
| Common or Proper name | 10 mg/ml Vinorelbine (as vinorelbine tartrate) | 10 mg/ml Vinorelbine (as vinorelbine tartrate) |
| Company Name | GENERIC MEDICAL PARTNERS INC | GENERIC MEDICAL PARTNERS INC |
| Ingredients | VINORELBINE | VINORELBINE |
| Strength(s) | 10MG | 10MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 5ml in clear glass vial | 5ml in clear glass vial |
| Additional packaging sizes | ||
| ATC code | L01CA | L01CA |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2017-12-06 | 2017-12-06 |
| Estimated end date (Changed) | Updated to: | Was: 2018-07-13 |
| Actual end date (Changed) | Updated to: 2018-08-01 | Was: |
| Shortage status (Changed) | Updated to: Resolved | Was: Actual shortage |
| Tier 3 Status | No | No |
| Company comments (Changed) | Updated to: New batches of 5 ml and 1 ml have been manufactured. Contracted 5 ml demand is now being supplied on allocated. Stock levels are being increased with the manufacture of further batches of both vial sizes. | Was: New batches have been produced. Planned release date expected 13 July 2018. |
| Health Canada comments |